annual blood borne pathogen training (healthcare & research version)

64
Annual Blood Borne Pathogen Training (Healthcare & Research version) Environmental Health & Safety Department Jay Abbt Daron White

Upload: garson

Post on 13-Jan-2016

16 views

Category:

Documents


3 download

DESCRIPTION

Annual Blood Borne Pathogen Training (Healthcare & Research version). Environmental Health & Safety Department Jay Abbt Daron White. Annual update for PVAMU employees with potential exposure to blood or other potentially infectious materials (OPIM ). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Annual Blood Borne Pathogen Training (Healthcare & Research version)

Environmental Health & Safety Department

Jay Abbt

Daron White

Page 2: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• Annual update for PVAMU employees with potential exposure to blood or other potentially infectious materials (OPIM)

Page 3: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

The following program meets the training requirements set forth by the OSHA Bloodborne Pathogens Standard.

This training module is a self-study designed to provide a review of the following:

• Bloodborne pathogens (BBP)

• Modes of transmission of BBP

• Exposure control principles and practices as they relate to bloodborne pathogens

Page 4: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Bloodborne Pathogens Standard

• OSHA (1991)- “Occupational Exposure to Bloodborne Pathogens” (29 CFR 1910.1030)

• Revised in 2001 in response to the Needlestick Safety and Prevention Act

Goal: eliminate or minimize occupational exposure to Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV), Hepatitis C virus (HCV), and other bloodborne pathogens

Page 5: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

What are Bloodborne Pathogens (BBP)?

• Any pathogenic microorganisms or OPIM (other potentially infectious materials) present in human blood that can cause disease in humans.

• Primary focus in our setting is HBV, HCV, and HIV- which will be detailed further in this presentation.

• Other examples of BBP include microorganisms that cause:

• malaria, syphilis, babesiosis, brucellosis, leptospirosis, arboviral infections, relapsing fever, Creutzfeldt-Jakob disease, HTLV-1, and viral hemorrhagic fever.

Page 6: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• We know blood and blood products are included in this BBP scope, but what are Other Potentially Infectious Materials (OPIM)?

Page 7: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

OPIM includes the following:

• Synovial, pleural, pericardial, and peritoneal fluid

• Cerebrospinal fluid• Semen• Vaginal secretions• Amniotic fluid• Saliva (in dental

procedures)

• Any unfixed tissue or organ from a human

• Any body fluid visibly contaminated with blood

• All body fluid where it is difficult to distinguish between body fluids

• Cell or tissue cultures that were HIV or HBV infected

Page 8: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• HBV, HIV, HCV

Let’s look at each of the BBP of concern in detail

Page 9: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Hepatitis B Virus (HBV)

• Hepatitis B is caused by a virus that attacks the liver and can cause lifelong infection, cirrhosis, liver cancer, liver failure, or death.

• In 2006, an estimated 46,000 people were newly infected with HBV. It is estimated that 1.25 million Americans are chronically infected.

Page 10: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Hepatitis B Virus

• HBV infection is a well recognized occupational risk for healthcare personnel.

• The average volume of blood inoculated during a needlestick injury with a 22-gauge needle is approximately 1 µl, a quantity sufficient to contain up to 100 infectious doses of HBV.

• HBV can survive outside the body at least 7 days and still be capable of causing infection.

Page 11: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Hepatitis B Virus

• About 30% of infected persons have no sign or symptoms of HBV.

• If symptoms occur, they usually begin to appear on the average of 12 weeks (range 9-21 weeks) after exposure to hepatitis B virus.

• If you have symptoms, they might include:• jaundice • abdominal discomfort• dark urine • clay-colored bowel movements • joint pain • fatigue• loss of appetite • nausea

Page 12: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HBV IS PREVENTABLE!A safe & effective vaccine is available.• Hepatitis B vaccine prevents hepatitis B infection

and its serious consequences.

• If the vaccine is administered before infection, it prevents the development of the disease and the carrier state in almost all individuals.

• Hepatitis B vaccine consists of a series of three injections – initial, one a month later, and one six months from the first.

• Available FREE of charge from employer for high-risk employees

Page 13: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

What treatment is available for HBV?

• In the occupational setting, multiple doses of Hepatitis B Immune Globulin initiated within 1 week following percutaneous exposure to hepatitis B surface antigen-positive blood provides an estimated 75% protection from HBV infection.

• There is no cure available for acute HBV infection. There are antiviral drugs available for the treatment of chronic HBV infection.

Page 14: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HIV• HIV (human immunodeficiency virus)

is the virus that causes AIDS (Acquired Immune Deficiency Syndrome). Once a person has been infected with HIV, it may be many years before AIDS actually develops.

• HIV kills or damages cells in the body’s immune system, gradually destroying the body’s ability to fight infection and certain cancers.

Page 15: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HIV

As of December 2001, occupational exposure to HIV has resulted in 57 documented cases of HIV seroconversion among healthcare personnel (HCP) in the United States.

At the end of 2003, an estimated 1,039,000 to 1,185,000 persons in the United States were living with HIV/AIDS, with 24-27% undiagnosed and unaware of their HIV infection.

Page 16: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HIV

• Some infected with HIV have no symptoms for up to ten years.

• Within a month or two after exposure to the virus some experience flu-like illness such as:

• fever, headache, fatigue, weight loss, diarrhea, night sweats, enlarged lymph nodes

• These symptoms usually disappear within a week to a month and are often mistaken for those of another viral infection. During this period, the individual is very infectious.

Page 17: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HIV

• The average risk for HIV transmission after a percutaneous exposure to HIV-infected blood has been estimated to be approximately 0.3%.

• HIV does not survive well outside the body, making the possibility of environmental transmission remote.

Page 18: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HIV- no cure or vaccine available• Treatment protocols from the U.S. Public Health Service

have been developed using antiretroviral agents from five classes of drugs to treat HIV infection. These include:

• the nucleoside reverse transcriptase inhibitors, nucleotide reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, protease inhibitors, and a single fusion inhibitor.

• The recommendations provide guidance to effectively suppress the virus on the basis of HIV transmission risk represented by the exposure.

Page 19: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HIV• Side effects associated with the use of antiviral drugs can

be severe.

• The drug regimen is not a cure for AIDS, but it has greatly improved the health of many people with AIDS and it reduces the amount of virus circulating in the blood to nearly undetectable levels.

• Researchers, however, have shown that HIV remains present in hiding places such as the lymph nodes even in people who have been treated.

Page 20: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HCV

• Hepatitis C virus is a liver disease

• After a needlestick or sharps exposure to HCV positive blood , about 1.8% healthcare workers will get infected with HCV.

• Estimated 4.1 million (1.6%) Americans have been infected with HCV, of whom 3.2 million are chronically infected.

Page 21: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HCV

Long term effects of HCV:

• Chronic infection: 75%-85% of infected persons

• Cirrhosis: 20% of chronically infected persons

• Deaths from chronic liver disease: 1%-5% of infected persons may die

• Leading indication for liver transplant

Page 22: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HCV

• jaundice

• fatigue

• dark urine

• abdominal pain 

• loss of appetite

• nausea

80% of persons infected have no signs or symptoms for HCV. When present, symptoms may include:

Page 23: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HCV• Currently, there is no cure for hepatitis C, and no

effective vaccine is currently available.

• National recommendations for the control of occupational exposure to HCV rely more on the prevention of transmission. In addition, several blood tests that measure either antibodies to HCV or HCV-RNA are available for hepatitis C screening. These tests are useful in determining current immune status and monitoring ongoing infection.

Page 24: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• How might I get exposed in the workplace?

How does a bloodborne infection occur?

Page 25: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Chain of Infection

Infection Control = Break any link in the chain

Page 26: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Modes of transmission of BBP

• Percutaneous - the direct inoculation of infectious material by piercing through the skin barrier (needlestick or other accidental injury with a sharp, contaminated object)

Penetration by contaminated sharps is the most common mode of transmission of bloodborne pathogens in the workplace.

Page 27: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Modes of transmission of BBP

• Direct inoculation - exposure of blood or OPIM to pre-existing lesions, cuts, abrasions, or rashes (dermatitis) provides a route of entry into the body.

• Mucous membrane contact - splashing blood or serum into an individual's unprotected eyes, nose, or mouth in clinical or laboratory settings poses a genuine risk of infection.

Page 28: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Duties that might put you at risk for an occupational exposure:

• Perform drawing of blood from human patients or animals

• Process blood for experimentation• Work with human or animal blood or body fluids• Use unfixed tissue in preparations or

experimentation• Work in an area where HIV or HBV research is

being performed or produced• Clean glassware contaminated with blood or OPIM

Page 29: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Duties that might put you at risk for an occupational exposure:

• Dispose of waste contaminated with blood or OPIM

• Transport blood or OPIM• Work in a laboratory where equipment or work

benches can become contaminated• Handle containers of infectious wastes• Clean blood spills, including dried blood• Handle laundry that contains sharps or is soiled

with blood or OPIM • Perform lifesaving procedures

Page 30: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• Pathogenicity of organism

• Dose (how much blood or infectious agent)

• Route of entry (injection vs. contact with mucous membrane or open wound)

• Host susceptibility

• Work practices

Risk Factors for Infection

Page 31: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• Now that we have reviewed how an exposure can occur, let’s look at how to prevent exposure.

Page 32: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Occupational Exposure Prevention

The risk of occupational exposure can be minimized or eliminated using a combination of engineering and work practice controls, personal protective clothing and equipment, training, medical surveillance, HBV vaccination, warning signs or labels, and other provisions described in this training section.  

Page 33: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Standard Precautions

• Guidelines to decrease the risk of occupational exposure to blood or body fluids

• A system of infection control which assumes that every direct contact with body fluids is infectious and requires every employee exposed to direct contact with body fluids to be protected as though such body fluids were infected with a bloodborne pathogen

• Provides adequate protection against bloodborne infections from both humans and animals

Page 34: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Employee Responsibilities

• Completing training/orientation as required• Following the Exposure Control Plan and the

Standard Precautions Policy• Using work practices, engineering controls,

and personal protective equipment as outlined in the Exposure Control Plan

• Obtaining the HBV vaccine or signing the declination form

Page 35: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Employee Responsibilities• Reporting exposure incidents to their

supervisor and assisting the supervisor in completing First Report of Injury Form

• Pursuing follow-up care after an occupational exposure

Failure to follow these policies could result in disciplinary action.

Page 36: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Exposure Control Plan

• Written plan provided to eliminate or minimize occupational exposure to BBP.

• PVAMU Safety Manual

• Can be obtained from EHS website.

• Reviewed annually.

Page 37: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Exposure Control Plan

Updates include:• Changes in technology that reduce/eliminate

exposure (engineering controls)• Annual documentation of consideration and

implementation of safer medical devices• Input from non-managerial employees (who

are responsible for direct patient care) in selecting and evaluating safer medical devices

Page 38: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Engineering Controls

• Sharps with Engineered Sharps Injury Protection (SESIP)– a non-needle sharp or needle with a built-in safety feature or mechanism that effectively reduces the risk of an exposure incident

Examples include: Self-sheathing syringe

Page 39: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

More Examples of Engineered Sharps Safety Devices

In use

Retractable lancets

Self-blunting needles

Retractable needle technology

Add-ons (needle covers)

After use

Page 40: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Engineering Controls• Needleless Systems = Device

that does not use a needle for:

• collection of body fluids• administration of

medication/fluids• any other procedure with

potential percutaneous

exposure to a contaminated sharp

Page 41: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Work Practice Controls• Contaminated needles/sharps shall not

be bent, recapped or removed unless there is no feasible alternative or if required by a specific medical procedure

• Such bending, recapping, or removal must be done though use of mechanical device or a one-handed technique

• Use puncture-resistant sharps container for disposal of sharps

Page 42: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Work Practice Controls• No food/drink/smoking, handling of contact

lenses, or application of cosmetics in work area where there is potential for exposure

• Minimize splashing, spraying, spattering, and generation of droplets

• No mouth pipetting• Use secondary containment for transport,

shipping, or storage of containers• Decontaminate surfaces and equipment

Page 43: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Handwashing• Employees must wash their hands

immediately or as soon as feasible after removal of gloves or other personal protective equipment.

• Wash as soon as possible if gross contamination occurs

• Alternate methods:– Antiseptic towelettes– Waterless handwashing gels

Page 44: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Personal Protective Equipment (PPE)

PPE is appropriate only if it does not permit blood/OPIM to pass through and/or reach the employee’s clothing, skin, eyes, mouth, or other mucous membranes under normal use.

Page 45: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Personal Protective Equipment• Gloves (latex or nonlatex)

– When to use them:• when there is reasonable anticipation

of employee hand contact with blood, OPIM, mucous membranes, or non-intact skin

• when performing vascular access procedures• when handling or touching contaminated surfaces

or items. – Remove prior to leaving the work area and discard as

biohazard waste

Page 46: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Latex Allergies

Latex gloves have proven effective in preventing transmission of many infectious diseases to health care workers. However, for some workers, exposures to latex may result in allergic reactions.

For further reading:

http://www.cdc.gov/niosh/topics/latex/

http://www.osha.gov/SLTC/latexallergy/index.html

Page 47: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Personal Protective Equipment

• Gowns, aprons, fluid-resistant clothing

• Face shields, eye protection (safety glasses, goggles)

• Respirators• Surgical caps, shoe covers

Page 48: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Even though the use of PPE is very important in controlling exposure to BBPs, it is your last line of defense against exposure if engineering and work practice controls fail.

• Do not rely only on PPE for protection.

Page 49: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Training• Training is required:

– at the time of initial employment and assignment

(or transfer) to job tasks where occupational exposure may occur

– within one year of the employee's previous training and annually thereafter (if the employee remains in an at-risk position)

– when changes such as modification of tasks or procedures or institution of new tasks or procedures affect the employee's potential for occupational exposures, and as new standards for safe work practices evolve.

Page 50: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

HBV Vaccination

• FREE to employee - paid for by your department if you are at high-risk for exposure

• If you initially refuse the vaccine, you may change your mind later and still receive it.

Page 51: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Warning Signs and Labels

• Fluorescent orange or orange-red label with word “Biohazard” and biohazard symbol in contrasting color must be provided on:

• Containers of regulated waste• Refrigerators/freezers used to store blood/OPIM• Containers used to store, transport, or ship

blood/OPIM• Contaminated equipment

• Red bags may be substituted for biohazard labels on biohazardous waste bags.

Page 52: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Housekeeping: Sharps Disposal

• Keep sharps container upright,

readily available in the work area

• Never place sharps into the regular trash

• Use a leak-proof, puncture-resistant

sharps container labeled with the biohazard symbol

• Do not overfill - dispose of sharps container as biohazard waste when it is 2/3 full

Page 53: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Housekeeping: Decontamination

Work surfaces should be decontaminated with an appropriate disinfectant such as 10% bleach solution or an EPA approved disinfectant after completion of procedures, immediately or as soon as feasible when surfaces are overtly contaminated or after any spill, and at the end of the work shift.

Page 54: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Where do I go and what must I do if I am exposed?

Page 55: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

What to Do: Post-Exposure

• Wash exposed area with soap and water for 5 minutes – if eye or mucous membrane contact, flush with sterile water or saline

for 5 minutes

• Report the incident to your supervisor, EHS AND Health Center immediately.

• Complete First Report of Injury Form • Report to Health enter for medical evaluation

Page 56: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Post-Exposure: General Medical Surveillance

• Any bloodborne pathogens exposure incident is an event for which immediate attention must be sought, as the effectiveness of prophylaxis depends on the immediacy of its delivery.

• Seek medical attention in the same manner that it would be sought should any occupational injury occur (e.g., emergency room, physician's office, urgent care clinic). You should not use your personal insurance when receiving care for an occupational injury/exposure.

Page 57: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

• Don’t delay in reporting for medical care - early treatment can mean the difference between life and death!

Page 58: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Recordkeeping• Injury Log

– Maintained by Human Resources in cooperation with Environmental Health & Safety Department.

– Contains necessary documented information for each needlestick/sharp related incident:

• type and brand of device involved • department or area of incident• description of incident

• Training records – 3 years

Page 59: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Recordkeeping

• Confidential medical records – duration

of employment + 30 years

• EPINet (Exposure Prevention Information Network) forms– helps to track trends, problem areas, types of

medical devices, etc. related to BBP occupational exposure incidents and injuries

• First Report of Injury and Illness Form

Page 60: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

REMEMBER:Don't wait.

Immediately report all exposures.

You may have to make a quick decision about starting an antiretroviral agent as prophylaxis. The time frame for beginning this treatment is critical. Reporting is also essential for establishing a claim

for Workers' Compensation benefits.

PVAMU’s Workers’ Compensation Specialist can be reached at (936) 261-1728

Page 61: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Summary of Post-Exposure Employee Responsibilities

1. Wash/flush exposed injury area for 5 minutes.

2. Promptly report the incident to your supervisor and the Bloodborne Pathogens Coordinator.

3. Complete the First Report of Injury forms.

4. Report to Health Clinic for medical evaluation.

Page 62: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

*Reminder*• PVAMU encourages you to contact you’re

the Health Center, Environmental Health & Safety or supervisor for questions, comments, or suggestions.

Health Center (936) 261-1400

Env. Health & Safety (936) 261-1745 or 1746

Workers Compensation (936) 261-1728

Page 63: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Why was this training so vital?

• Healthcare and research personnel are at a great risk for occupational exposure to bloodborne pathogens.

• Through information and awareness PVAMU aims to minimize any risk to our employees and continue the commitment to safety in the workplace.

Page 64: Annual Blood Borne Pathogen Training   (Healthcare & Research version)

Quiz required for Training credit

• Thank you for completing the self-study review session. Please click below to assess your learning and receive credit for participation.

• Take Quiz